1 |
Bentzen SM, Parliament M, Deasy JO, Dicker A, Curran WJ, Williams JP, et al. Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S145-S150.
DOI
|
2 |
Luhr A, von Neubeck C, Krause M, Troost EGC. Relative biological effectiveness in proton beam therapy - current knowledge and future challenges. Clin Transl Radiat Oncol. 2018;9:35-41.
DOI
|
3 |
McMahon SJ. The linear quadratic model: usage, interpretation and challenges. Phys Med Biol. 2018;64:01TR01.
DOI
|
4 |
Schlaff CD, Krauze A, Belard A, O'Connell JJ, Camphausen KA. Bringing the heavy: carbon ion therapy in the radiobiological and clinical context. Radiat Oncol. 2014;9:88.
DOI
|
5 |
Grun R, Friedrich T, Traneus E, Scholz M. Is the doseaveraged LET a reliable predictor for the relative biological effectiveness? Med Phys. 2019;46:1064-1074.
DOI
|
6 |
Stavrev P, Stavreva N, Ruggieri R, Nahum A. On differences in radiosensitivity estimation: TCP experiments versus survival curves. a theoretical study. Phys Med Biol. 2015;60:N293-N299.
DOI
|
7 |
Abolfath R, Peeler CR, Newpower M, Bronk L, Grosshans D, Mohan R. A model for relative biological effectiveness of therapeutic proton beams based on a global fit of cell survival data. Sci Rep. 2017;7:8340.
DOI
|
8 |
Glatstein E. The omega on alpha and beta. Int J Radiat Oncol Biol Phys. 2011;81:319-320.
DOI
|
9 |
Scholz M, Kellerer AM, Kraft-Weyrather W, Kraft G. Computation of cell survival in heavy ion beams for therapy. the model and its approximation. Radiat Environ Biophys. 1997;36:59-66.
DOI
|
10 |
Elsasser T, Scholz M. Cluster effects within the local effect model. Radiat Res. 2007;167:319-329.
DOI
|
11 |
Elsasser T, Kramer M, Scholz M. Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo. Int J Radiat Oncol Biol Phys. 2008;71:866-872.
DOI
|
12 |
Elsasser T, Weyrather WK, Friedrich T, Durante M, Iancu G, Kramer M, et al. Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning. Int J Radiat Oncol Biol Phys. 2010;78:1177-1183.
DOI
|
13 |
Stewart RD, Carlson DJ, Butkus MP, Hawkins R, Friedrich T, Scholz M. A comparison of mechanism-inspired models for particle relative biological effectiveness (RBE). Med Phys. 2018;45:e925-e952.
|
14 |
Scholz M, Kraft G. Track structure and the calculation of biological effects of heavy charged particles. Adv Space Res. 1996;18:5-14.
DOI
|
15 |
Elsasser T, Cunrath R, Kramer M, Scholz M. Impact of track structure calculations on biological treatment planning in ion radiotherapy. New J Phys. 2008;10:075005.
DOI
|
16 |
Kellerer AM, Rossi HH. A generalized formulation of dual radiation action. Radiat Res. 2012;178:AV204-AV213.
DOI
|
17 |
Hawkins RB. A statistical theory of cell killing by radiation of varying linear energy transfer. Radiat Res. 1994;140:366-374.
DOI
|
18 |
Kase Y, Kanai T, Matsumoto Y, Furusawa Y, Okamoto H, Asaba T, et al. Microdosimetric measurements and estimation of human cell survival for heavy-ion beams. Radiat Res. 2006;166:629-638.
DOI
|
19 |
Durante M, Debus J. Heavy charged particles: does improved precision and higher biological effectiveness translate to better outcome in patients? Semin Radiat Oncol. 2018;28:160-167.
DOI
|
20 |
Inaniwa T, Furukawa T, Kase Y, Matsufuji N, Toshito T, Matsumoto Y, et al. Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model. Phys Med Biol. 2010;55:6721-6737.
DOI
|
21 |
Karger CP, Peschke P. RBE and related modeling in carbon-ion therapy. Phys Med Biol. 2017;63:01TR02.
DOI
|
22 |
Fossati P, Matsufuji N, Kamada T, Karger CP. Radiobiological issues in prospective carbon ion therapy trials. Med Phys. 2018;45:e1096-e1110.
|
23 |
Loeffler JS, Durante M. Charged particle therapy--optimization, challenges and future directions. Nat Rev Clin Oncol. 2013;10:411-424.
DOI
|
24 |
Wang T, Xiao P, Jia S, Yuan K, Yang H. [The basic structure of heavy-ion tumor therapy facility]. Zhongguo Yi Liao Qi Xie Za Zhi. 2014;38:427-429, 438. Chinese.
|
25 |
Ebner DK, Kamada T. The emerging role of carbon-ion radiotherapy. Front Oncol. 2016;6:140.
|
26 |
Mohamad O, Makishima H, Kamada T. Evolution of carbon ion radiotherapy at the National Institute of Radiological Sciences in Japan. Cancers (Basel). 2018;10:E66.
|
27 |
Lazar AA, Schulte R, Faddegon B, Blakely EA, Roach M 3rd. Clinical trials involving carbon-ion radiation therapy and the path forward. Cancer. 2018;124:4467-4476.
DOI
|
28 |
World Health Organization. International Clinical Trials Registry Platform Search Portal. Geneva: World Health Organization [cited 2020 Jan 6]. Available from: http://apps.who.int/trialsearch/default.aspx.
|
29 |
Grun R, Friedrich T, Elsasser T, Kramer M, Zink K, Karger CP, et al. Impact of enhancements in the local effect model (LEM) on the predicted RBE-weighted target dose distribution in carbon ion therapy. Phys Med Biol. 2012;57:7261-7274.
DOI
|